pillbase.ru

Angiox

Active substance: bivalirudin

Bivalirudin

Centralised EU authorisationWithdrawn

Marketing holder: The Medicines Company UK Ltd

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 13
  • BIVALIRUDIN
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BIVALIRUDIN 250 mg/5mL
    71288-427
    Meitheal Pharmaceuticals Inc.
  • BIVALIRUDIN
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BIVALIRUDIN 250 mg/1
    55150-210
    Eugia US LLC
  • Bivalirudin
    INJECTION, SOLUTION · BIVALIRUDIN 250 mg/1
    42023-622
    Par Health USA, LLC
  • Bivalirudin
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BIVALIRUDIN 250 mg/1
    83634-400
    Avenacy, LLC
  • Bivalirudin
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BIVALIRUDIN 250 mg/1
    63323-562
    Fresenius Kabi USA, LLC
All products in this country (13)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5982-7135-a44f-e3627116da35,01a1208c-c1d3-765b-ba49-ce2e95370e15,01a1208d-d98b-7b3a-a4ca-9bbaf912fb16,01a1208e-d7da-7c4f-a635-d66b07491c62,01a12090-4162-7455-b951-3ce8a6b26062;count=13 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000562
Registration status
Withdrawn
ATC code
B01AE06
Sources
  • product · EMA · EMEA/H/C/000562 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000562 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000562 · Verified 2026-10-09